Product/Composition:- | Ivermectin tablets |
---|---|
Strength:- | 3 mg |
Form:- | Tablet |
Reference Brands:- | Stromectol(US) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Ivermectin tablets work by binding to parasite nerve and muscle receptors, causing paralysis and death. They effectively treat parasitic infections like onchocerciasis and strongyloidiasis. Benefits include rapid parasite clearance, improved symptoms, and reduced transmission, making ivermectin a cornerstone in antiparasitic therapy.
Ivermectin tablets are approved in the US and EU for treating parasitic infections, with regulatory oversight from the FDA and EMA. Their dossiers include comprehensive safety, efficacy, and manufacturing data, ensuring high-quality standards. In the US, ivermectin is approved for specific indications, while in the EU, it adheres to strict EMA regulations. Regulatory approval involves rigorous clinical evaluation, documentation, and compliance checks. For detailed insights into ivermectin’s regulatory status, approved dossiers, and market authorization processes, visit Pharmatradz. Stay informed on the latest regulatory updates and licensing requirements for ivermectin tablets in global markets.